Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

RPRX – Royalty Pharma plc

Royalty Pharma plc
RPRX
$32.20
Name : Royalty Pharma plc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $18,395,279,360.00
EPSttm : 1.91
finviz dynamic chart for RPRX
Royalty Pharma plc
$32.20
0.53%
$0.17

Float Short %

5.39

Margin Of Safety %

41

Put/Call OI Ratio

0.17959734839185

EPS Next Q Diff

-0.12

EPS Last/This Y

2.57

EPS This/Next Y

0.32

Price

32.2

Target Price

39.8

Analyst Recom

1.5

Performance Q

3.67

Relative Volume

0.75

Beta

0.48

Ticker: RPRX




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-27RPRX31.650.263.7341547
2025-03-28RPRX31.390.323.6742749
2025-03-31RPRX31.120.342.4743646
2025-04-01RPRX31.180.3510.3443976
2025-04-02RPRX31.280.3723.1544448
2025-04-03RPRX31.790.356.3443956
2025-04-04RPRX31.110.3415.5143556
2025-04-07RPRX31.040.300.4842153
2025-04-08RPRX30.860.300.0242137
2025-04-09RPRX32.260.300.0142108
2025-04-10RPRX31.230.295.0742230
2025-04-11RPRX31.940.314.8742891
2025-04-14RPRX32.290.323.8943230
2025-04-15RPRX32.460.330.1343466
2025-04-16RPRX32.20.330.0644277
2025-04-17RPRX32.60.330.0444243
2025-04-18RPRX32.60.330.0444243
2025-04-21RPRX32.190.171.1428560
2025-04-22RPRX32.190.189.6728688
2025-04-23RPRX31.680.1845.0028768
2025-04-24RPRX32.020.180.0028812
2025-04-25RPRX32.20.17959734839185028827
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-27RPRX31.648.3554.74.67
2025-03-28RPRX31.378.3537.84.67
2025-03-31RPRX31.138.3539.74.67
2025-04-01RPRX31.178.3553.34.67
2025-04-02RPRX31.288.3556.14.67
2025-04-03RPRX31.798.3574.94.67
2025-04-04RPRX31.128.3519.84.67
2025-04-07RPRX31.058.3547.74.67
2025-04-08RPRX30.858.3542.54.67
2025-04-09RPRX32.278.3618.54.67
2025-04-10RPRX31.228.3502.64.67
2025-04-11RPRX31.95-0.1585.94.44
2025-04-14RPRX32.29-0.1566.74.44
2025-04-15RPRX32.45-0.1558.34.49
2025-04-16RPRX32.20-0.1539.54.49
2025-04-17RPRX32.60-0.1569.94.49
2025-04-18RPRX32.60-0.1551.04.49
2025-04-21RPRX32.19-0.1532.24.49
2025-04-22RPRX32.19-0.1550.54.49
2025-04-23RPRX31.69-2.2527.94.48
2025-04-24RPRX32.03-2.2592.04.48
2025-04-25RPRX32.20-2.4583.34.49
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-27RPRX0.001.364.66
2025-03-28RPRX0.001.364.66
2025-03-31RPRX0.001.374.66
2025-04-01RPRX0.001.374.66
2025-04-02RPRX0.001.374.66
2025-04-03RPRX0.001.374.66
2025-04-04RPRX0.001.374.66
2025-04-07RPRX0.001.404.66
2025-04-08RPRX0.001.404.66
2025-04-09RPRX0.001.404.66
2025-04-10RPRX0.001.405.39
2025-04-11RPRX0.001.405.39
2025-04-14RPRX0.001.395.39
2025-04-15RPRX0.001.395.39
2025-04-16RPRX0.001.395.39
2025-04-17RPRX0.001.395.39
2025-04-18RPRX0.001.395.39
2025-04-21RPRX0.001.675.39
2025-04-22RPRX0.001.675.39
2025-04-23RPRX0.001.675.39
2025-04-24RPRX0.001.675.39
2025-04-25RPRX0.001.675.39
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

1.15

Avg. EPS Est. Current Quarter

1.06

Avg. EPS Est. Next Quarter

1.03

Insider Transactions

Institutional Transactions

1.67

Beta

0.48

Average Sales Estimate Current Quarter

724

Average Sales Estimate Next Quarter

657

Fair Value

45.55

Quality Score

69

Growth Score

54

Sentiment Score

60

Actual DrawDown %

43

Max Drawdown 5-Year %

Target Price

39.8

P/E

16.79

Forward P/E

6.26

PEG

1.46

P/S

8.17

P/B

2.07

P/Free Cash Flow

6.62

EPS

1.92

Average EPS Est. Cur. Y​

4.49

EPS Next Y. (Est.)

4.8

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

37.93

Relative Volume

0.75

Return on Equity vs Sector %

-8.8

Return on Equity vs Industry %

6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.18

EBIT Estimation

583.3
Royalty Pharma plc
Sector: Healthcare
Industry: Biotechnology
Employees:
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
stock quote shares RPRX – Royalty Pharma plc Stock Price stock today
news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025
marketwatch RPRX – Royalty Pharma plc yahoo finance google finance
stock history RPRX – Royalty Pharma plc invest stock market
stock prices RPRX premarket after hours
ticker RPRX fair value insiders trading